Sinorda Biomedicine — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Biotech company engineering multi-specific antibody therapeutics for cancer and immunological disorders.

OncologyImmunology

Proprietary antibody engineering platform for designing and developing multi-specific antibody therapeutics.

Potential to address unmet needs in oncology and autoimmunity with novel mechanisms and secure lucrative partnership deals.

High technical and clinical development risk inherent to novel biologic formats and crowded target spaces.

Operates in the highly competitive bispecific/multi-specific antibody space, competing on technological innovation and novel target selection.